πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
12,558
Companies
407
Drugs tracked
2,719

Quick answer

NovaPharmaNews tracks 12,558 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

Showing page 44 of 524 Β· Phase 3 first, then by program name

  1. Linaclotide

    IRONWOOD PHARMACEUTICALS INC

    Chronic Idiopathic Constipation

    phase 3 small molecule completed

    1 trial

  2. Linaclotide

    IRONWOOD PHARMACEUTICALS INC

    Functional Constipation

    phase 3 small molecule completed

    3 trials

  3. Linaclotide 290 micrograms

    IRONWOOD PHARMACEUTICALS INC

    Chronic Constipation

    phase 3 small molecule completed

    2 trials

  4. Linaclotide 290 micrograms

    IRONWOOD PHARMACEUTICALS INC

    Irritable Bowel Syndrome Characterized by Constipation

    phase 3 small molecule completed

    1 trial

  5. Linaclotide or Matching Placebo

    IRONWOOD PHARMACEUTICALS INC

    Irritable Bowel Syndrome With Constipation

    phase 3 small molecule completed

    1 trial

  6. Linvoseltamab

    REGENERON PHARMACEUTICALS, INC.

    Relapsed Refractory Multiple Myeloma (RRMM)

    phase 3 small molecule active

    2 trials

  7. Linvoseltamab

    REGENERON PHARMACEUTICALS, INC.

    Relapsed and/or Refractory Multiple Myeloma (RRMM)

    phase 3 small molecule active

    1 trial

  8. Linvoseltamab

    REGENERON PHARMACEUTICALS, INC.

    Multiple Myeloma (MM)

    phase 3 small molecule active

    1 trial

  9. Linvoseltamab

    REGENERON PHARMACEUTICALS, INC.

    Multiple Myeloma

    phase 3 small molecule active

    6 trials

  10. Linvoseltamab

    REGENERON PHARMACEUTICALS, INC.

    High Risk Smoldering Multiple Myeloma (HR-SMM)

    phase 3 small molecule active

    1 trial

  11. Lipid-lowing Tea

    China SXT Pharmaceuticals

    Hyperlipidemia

    phase 3 small molecule active

    1 trial

  12. Liposomal bupivacaine

    Pacira BioSciences

    Surgery

    phase 3 small molecule completed

    1 trial

  13. Lisdexamfetamine Dimesylate (LDX)

    TAKEDA PHARMACEUTICAL CO LTD

    ADHD

    phase 3 small molecule completed

    3 trials

  14. Lisdexamfetamine dimesylate

    TAKEDA PHARMACEUTICAL CO LTD

    Binge Eating Disorder

    phase 3 small molecule completed

    2 trials

  15. Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab

    China SXT Pharmaceuticals

    Immunoglobulin Light-chain Amyloidosis

    phase 3 small molecule active

    1 trial

  16. Live Combined Bifidobacterium and Lactobacillus Tablets、Compound Glutamine Entersoluble capsules

    China SXT Pharmaceuticals

    Radiation Proctitis

    phase 3 small molecule active

    1 trial

  17. Live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd

    SINOVAC BIOTECH LTD

    Varicella

    phase 3 mab active

    1 trial

  18. Live-Attenuated influenza Vaccine(LAIV)

    BRIGHT MINDS BIOSCIENCES INC.

    Influenza

    phase 3 mab completed

    1 trial

  19. Lixivaptan

    Centessa Pharmaceuticals plc

    Polycystic Kidney Disease, Adult

    phase 3 small molecule terminated

    2 trials

  20. Lixivaptan

    Centessa Pharmaceuticals plc

    Autosomal Dominant Polycystic Kidney

    phase 3 small molecule terminated

    1 trial

  21. Lofexidine

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Addiction

    phase 3 small molecule completed

    1 trial

  22. Lofexidine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Withdrawal

    phase 3 small molecule completed

    1 trial

  23. Lofexidine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 3 small molecule completed

    3 trials

  24. Lofexidine HCl

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 12,558 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources